ANEBULO PHARMACEUTICALS INC's ticker is ANEB and the CUSIP is 034569103. A total of 10 filers reported holding ANEBULO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,104 | -48.7% | 1,696 | -39.0% | 0.00% | – |
| Q3 2022 | $8,000 | -46.7% | 2,781 | -4.4% | 0.00% | – |
| Q2 2022 | $15,000 | 0.0% | 2,909 | +34.9% | 0.00% | – |
| Q1 2022 | $15,000 | +275.0% | 2,156 | +271.7% | 0.00% | – |
| Q4 2021 | $4,000 | -33.3% | 580 | -31.6% | 0.00% | – |
| Q3 2021 | $6,000 | +200.0% | 848 | +262.4% | 0.00% | – |
| Q2 2021 | $2,000 | – | 234 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 22NW, LP | 5,066,290 | $12,279,167 | 6.63% |
| Praetorian Capital Management LLC | 180,005 | $436,278 | 0.35% |
| LVW Advisors, LLC | 673,914 | $1,633,365 | 0.33% |
| Ikarian Capital, LLC | 156,203 | $374,888 | 0.09% |
| Nantahala Capital Management | 511,073 | $1,238,688 | 0.08% |
| MANGROVE PARTNERS IM, LLC | 399,219 | $967,587 | 0.06% |
| Herr Investment Group LLC | 29,644 | $71,848 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 17,319 | $41,976 | 0.00% |
| Tower Research Capital LLC (TRC) | 3,597 | $9 | 0.00% |
| UBS Group AG | 1,696 | $4,104 | 0.00% |